Table 1 Characteristics of the women included in the study. Intention-to-treat analysis
Hospital A | Hospital B | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intervention Group | Control Group | Intervention Group | Control Group | Intervention Group | Control Group | |||||||
n | % | n | % | n | % | n | % | n | % | n | % | |
Age (median and IQR) | 57 | 53–62 | 57 | 53–62 | 58 | 54–63 | 58 | 54–63 | 58 | 53–63 | 58 | 54–63 |
Place of birth | ||||||||||||
Spain | 1460 | 56.8% | 1418 | 56.2% | 1956 | 69.3% | 2203 | 69.5% | 3416 | 63.3% | 3621 | 63.6% |
Europe or North America | 143 | 5.6% | 174 | 6.9% | 108 | 3.8% | 107 | 3.4% | 251 | 4.7% | 281 | 4.9% |
Center or South America | 301 | 11.7% | 292 | 11.6% | 220 | 7.8% | 261 | 8.2% | 521 | 9.7% | 553 | 9.7% |
Asia or Oceania | 515 | 20.0% | 448 | 17.8% | 33 | 1.2% | 42 | 1.3% | 548 | 10.2% | 490 | 8.6% |
Africa | 96 | 3.7% | 150 | 5.9% | 12 | 0.4% | 14 | 0.4% | 108 | 2.0% | 164 | 2.9% |
Missing | 55 | 2.1% | 40 | 1.6% | 494 | 17.5% | 545 | 17.2% | 549 | 10.2% | 585 | 10.3% |
Study level | ||||||||||||
Primary or less | 633 | 24.6% | 667 | 26.4% | 118 | 4.2% | 144 | 4.5% | 751 | 13.9% | 811 | 14.2% |
High-school or PT | 1098 | 42.7% | 1046 | 41.5% | 1543 | 54.7% | 1767 | 55.7% | 2641 | 49.0% | 2813 | 49.4% |
Higher level | 398 | 15.5% | 419 | 16.6% | 997 | 35.3% | 1066 | 33.6% | 1395 | 25.9% | 1485 | 26.1% |
Missing | 441 | 17.2% | 390 | 15.5% | 165 | 5.8% | 195 | 6.1% | 606 | 11.2% | 585 | 10.3% |
Initial or subsequent screening | ||||||||||||
Initial screening | 1188 | 46.2% | 1151 | 45.6% | 2101 | 74.4% | 2306 | 72.7% | 3289 | 61.0% | 3457 | 60.7% |
Subsequent screening | 1381 | 53.7% | 1371 | 54.4% | 722 | 25.6% | 866 | 27.3% | 2103 | 39.0% | 2237 | 39.3% |
Missing | 1 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 1 | 0.0% | 0 | 0.0% |
Total | 2570 | 100% | 2522 | 100% | 2823 | 100% | 3172 | 100% | 5393 | 100% | 5694 | 100% |